Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Claire Nicole Freemantle"'
Autor:
Paul Colville-Nash, Klaus Rüdiger Trott, Chandan Alam, Michael Seed, Claire Nicole Freemantle, Guido Hildebrandt
Publikováno v:
Strahlentherapie und Onkologie. 174:580-588
Substantial clinical evidence shows the efficacy of low-dose radiotherapy in the treatment of a wide variety of benign conditions. However, experimental investigations into these empirically clinical observations remain scarce. We investigated in viv
Autor:
Michael Seed, K. R. Trott, Paul Colville-Nash, Guido Hildebrandt, C. A. S. Alam, Claire Nicole Freemantle
Publikováno v:
Scopus-Elsevier
RT of benign diseases became unfashionable in some Purpose: To investigate the hypothesis that modulation of the countries following the publication of late harmful function of activated macrophages is one of the mechanisms of side ea ects (Cannon et
Autor:
C. A. S. Alam, Derek A. Willoughby, Mauro Perretti, Claire Nicole Freemantle, Martin J. Carrier, A. Divwedi, J. Brown, D. C. West, Paul Colville-Nash, Michael Seed, S. Gustafson
Publikováno v:
Inflammopharmacology. 12(5-6)
Objective: To study the effect of hyaluronan on cell adhesion and recruitment both in vitro and in vivo, since hyaluronan both inhibits restenosis and is anti-inflammatory. When administered to animals undergoing angioplasty the recruitment of cells
Autor:
Gemma Andrews, Paul Colville-Nash, Derek A. Willoughby, Dean Willis, Connie Lam, Claire Nicole Freemantle, Jonathan Papworth
Publikováno v:
Inflammopharmacology. 12(5-6)
The peroxisome proliferator-activated receptor system is exciting much interest as a novel point of therapeutic intervention in inflammation. Here, the effect of a peroxisome proliferator-activated receptor alpha agonist, [4-chloro-6-(2,3-xylidine)-p
Autor:
Derek A. Willoughby, Paul Colville-Nash, Michael Seed, Claire Nicole Freemantle, Joanne R. Brown, Kevin W. Somerville, Chandan Alam, Jonathan Papworth
Publikováno v:
Advances in Experimental Medicine and Biology ISBN: 9781489918123
The chronic administration of non-steroidal anti-inflammatory drugs (NSAIDs) results in reduced colonic adenocarcinoma incidence1. When administered to existing tumours, NSAIDs induce tumour regression2. Other states susceptible to NSAIDs include bas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ba0048c4d56b56acdc836ae5e0204b8
https://doi.org/10.1007/978-1-4899-1810-9_72
https://doi.org/10.1007/978-1-4899-1810-9_72
Autor:
Paul Colville-Nash, Michael Seed, Claire Nicole Freemantle, Joanne R. Brown, Derek A. Willoughby, Dean Willis, Elizabeth Wong, Kevin W. Somerville, Jilly F. Evans
Publikováno v:
Prostaglandins & Other Lipid Mediators. 59:61
Experimental and clinical studies have shown non-steroidal anti-inflammatory drugs (NSAIDs) as potential therapeutics in the treatment colorectal cancer. NSAIDs can reduce the relative risk of colorectal cancer in patients taking regular aspirin1. Al